AC2993 + AC2993 + Placebo + Placebo
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Diabetes Mellitus, Non-Insulin-Dependent
Conditions
Diabetes Mellitus, Non-Insulin-Dependent
Trial Timeline
May 1, 2002 → Aug 1, 2003
NCT ID
NCT00035984About AC2993 + AC2993 + Placebo + Placebo
AC2993 + AC2993 + Placebo + Placebo is a phase 3 stage product being developed by AstraZeneca for Diabetes Mellitus, Non-Insulin-Dependent. The current trial status is completed. This product is registered under clinical trial identifier NCT00035984. Target conditions include Diabetes Mellitus, Non-Insulin-Dependent.
What happened to similar drugs?
20 of 20 similar drugs in Diabetes Mellitus, Non-Insulin-Dependent were approved
Approved (20) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00035984 | Phase 3 | Completed |
| NCT00039013 | Phase 3 | Completed |
| NCT00039026 | Phase 3 | Completed |
Competing Products
20 competing products in Diabetes Mellitus, Non-Insulin-Dependent